相关实验视频

Updated: Jun 3, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

TClC通过多药理学有效抑制NSCLC的生长和转移

Jing Lu¹, Ying Zhang^1,2,3, Chunyan Yan^1,4

¹School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, 264005, China.

Bioactive materials

|January 6, 2025

概括

一种新的化合物TClC通过向多种癌症途径,有效地抑制非小细胞肺癌 (NSCLC) 的生长和转移. 这种新型疗法对治疗耐药NSCLC而没有毒性有前途.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

非小细胞肺癌 (NSCLC) 仍然是一个重大的全球卫生挑战,生存率很低,通常是由于治疗耐药性和转移.
针对性治疗和免疫疗法等现有疗法在克服NSCLC药物耐药性和转移性进展方面存在局限性.

研究的目的:

合成和评估一种新的生物活性化合物,乙基6 - 黄-3 - 碳糖L - 氨酸 (TClC),对其针对NSCLC的疗效.
研究TClC的作用机制,特别是对癌症干细胞和抗药性途径的影响.

主要方法:

新型化合物TClC的合成.
试验室和体内研究评估TClC对NSCLC生长,上皮介质转变 (EMT),迁移,入侵和转移的影响.
分子测定以确定TClC的直接结合标.

主要成果:

在体外,TCLC显著抑制NSCLC生长,EMT,迁移和入侵,并在体内减少瘤生长和转移,没有观察到毒性.
在CD133阳性NSCLC细胞中,TClC破坏了自环,这对转移至关重要.
TClC的直接分子标被确定为Akt,NF-κB,β-catenin,EZH2和PD-L1,导致瘤原因子的抑制和多药物耐药性.

结论:

TClC对NSCLC具有显著的抗癌活性,包括耐药和转移的形式.
该化合物的多药性作用,准多个关键癌症途径,使其成为一个有前途的治疗候选者.
通过向瘤进展和耐药性的关键驱动因素,TCLC代表了NSCLC治疗发展的潜在新时代.

关键词:

癌症干细胞标记物癌症干细胞标记物转移转移转移转移非小细胞肺癌是非小细胞肺癌.多种药物效应的多种药物效应.茶叶衍生品茶叶衍生品

更多相关视频

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...